vs
因美纳（ILMN）与沃特世（WAT）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是沃特世的1.2倍（$1.1B vs $932.4M）。沃特世净利率更高（24.2% vs 16.8%，领先7.3%）。沃特世同比增速更快（6.8% vs -1.6%）。过去两年沃特世的营收复合增速更高（21.0% vs 0.8%）
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
沃特世是总部位于美国马萨诸塞州米尔福德的企业，面向生命科学、材料、食品等行业，提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件，为各领域的检测、研发等工作提供可靠技术支持。
ILMN vs WAT — 直观对比
营收规模更大
ILMN
是对方的1.2倍
$932.4M
营收增速更快
WAT
高出8.4%
-1.6%
净利率更高
WAT
高出7.3%
16.8%
两年增速更快
WAT
近两年复合增速
0.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $932.4M |
| 净利润 | $186.0M | $225.2M |
| 毛利率 | 65.9% | 61.1% |
| 营业利润率 | 15.8% | 29.0% |
| 净利率 | 16.8% | 24.2% |
| 营收同比 | -1.6% | 6.8% |
| 净利润同比 | 205.7% | -2.7% |
| 每股收益（稀释后） | $1.16 | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ILMNWAT
| Q4 25 | — | $932.4M | ||
| Q3 25 | — | $799.9M | ||
| Q2 25 | — | $771.3M | ||
| Q1 25 | — | $661.7M | ||
| Q4 24 | $1.1B | $872.7M | ||
| Q3 24 | $1.1B | $740.3M | ||
| Q2 24 | $1.1B | $708.5M | ||
| Q1 24 | $1.1B | $636.8M |
净利润ILMNWAT
| Q4 25 | — | $225.2M | ||
| Q3 25 | — | $148.9M | ||
| Q2 25 | — | $147.1M | ||
| Q1 25 | — | $121.4M | ||
| Q4 24 | $186.0M | $231.4M | ||
| Q3 24 | $705.0M | $161.5M | ||
| Q2 24 | $-2.0B | $142.7M | ||
| Q1 24 | $-126.0M | $102.2M |
毛利率ILMNWAT
| Q4 25 | — | 61.1% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 58.2% | ||
| Q4 24 | 65.9% | 60.1% | ||
| Q3 24 | 69.0% | 59.3% | ||
| Q2 24 | 64.8% | 59.3% | ||
| Q1 24 | 62.0% | 58.9% |
营业利润率ILMNWAT
| Q4 25 | — | 29.0% | ||
| Q3 25 | — | 24.0% | ||
| Q2 25 | — | 24.4% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | 15.8% | 33.5% | ||
| Q3 24 | 68.6% | 28.5% | ||
| Q2 24 | -147.2% | 26.7% | ||
| Q1 24 | -10.3% | 21.0% |
净利率ILMNWAT
| Q4 25 | — | 24.2% | ||
| Q3 25 | — | 18.6% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | 16.8% | 26.5% | ||
| Q3 24 | 65.3% | 21.8% | ||
| Q2 24 | -178.8% | 20.1% | ||
| Q1 24 | -11.7% | 16.0% |
每股收益（稀释后）ILMNWAT
| Q4 25 | — | $3.76 | ||
| Q3 25 | — | $2.50 | ||
| Q2 25 | — | $2.47 | ||
| Q1 25 | — | $2.03 | ||
| Q4 24 | $1.16 | $3.88 | ||
| Q3 24 | $4.42 | $2.71 | ||
| Q2 24 | $-12.48 | $2.40 | ||
| Q1 24 | $-0.79 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.0M | $587.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $2.4B | $2.6B |
| 总资产 | $6.3B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.55× |
8季度趋势，按日历期对齐
现金及短期投资ILMNWAT
| Q4 25 | — | $587.8M | ||
| Q3 25 | — | $459.1M | ||
| Q2 25 | — | $367.2M | ||
| Q1 25 | — | $382.9M | ||
| Q4 24 | $93.0M | $325.4M | ||
| Q3 24 | $70.0M | $331.5M | ||
| Q2 24 | $74.0M | $327.4M | ||
| Q1 24 | — | $338.2M |
总债务ILMNWAT
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ILMNWAT
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $2.4B | $1.8B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $1.4B | $1.4B | ||
| Q1 24 | $5.7B | $1.3B |
总资产ILMNWAT
| Q4 25 | — | $5.1B | ||
| Q3 25 | — | $4.9B | ||
| Q2 25 | — | $4.7B | ||
| Q1 25 | — | $4.6B | ||
| Q4 24 | $6.3B | $4.6B | ||
| Q3 24 | $6.0B | $4.5B | ||
| Q2 24 | $6.1B | $4.4B | ||
| Q1 24 | $10.0B | $4.5B |
负债/权益比ILMNWAT
| Q4 25 | — | 0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $364.0M | $164.6M |
| 自由现金流经营现金流 - 资本支出 | $335.0M | — |
| 自由现金流率自由现金流/营收 | 30.3% | — |
| 资本支出强度资本支出/营收 | 2.6% | — |
| 现金转化率经营现金流/净利润 | 1.96× | 0.73× |
| 过去12个月自由现金流最近4个季度 | $709.0M | — |
8季度趋势，按日历期对齐
经营现金流ILMNWAT
| Q4 25 | — | $164.6M | ||
| Q3 25 | — | $187.3M | ||
| Q2 25 | — | $41.1M | ||
| Q1 25 | — | $259.6M | ||
| Q4 24 | $364.0M | $240.1M | ||
| Q3 24 | $316.0M | $204.6M | ||
| Q2 24 | $80.0M | $54.5M | ||
| Q1 24 | $77.0M | $262.9M |
自由现金流ILMNWAT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $284.0M | — | ||
| Q2 24 | $49.0M | — | ||
| Q1 24 | $41.0M | — |
自由现金流率ILMNWAT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 30.3% | — | ||
| Q3 24 | 26.3% | — | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 3.8% | — |
资本支出强度ILMNWAT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 3.3% | — |
现金转化率ILMNWAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | 1.96× | 1.04× | ||
| Q3 24 | 0.45× | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ILMN
| Sequencing | $1.0B | 91% |
| Microarray | $101.0M | 9% |
| Investee | $7.0M | 1% |
WAT
暂无分部数据
